Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermaquel is a professional aesthetic medicine company based in Paris, France, that specializes in advanced dermatological solutions. The company develops and manufactures a comprehensive range of medical-grade chemical peels, mesotherapy cocktails, and specialized post-treatment skincare products. Their formulations are designed to address complex skin concerns such as photoaging, hyperpigmentation, and acne by utilizing high concentrations of pharmaceutical-grade active ingredients, including alpha-hydroxy acids and biomimetic peptides. Dermaquel primarily serves the professional market, providing dermatologists and aesthetic clinicians with tools for non-invasive skin rejuvenation. The brand is recognized for its focus on clinical efficacy and high-potency formulations within the global aesthetic sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermaquel Paris.